Frontier Wealth Management’s CervoMed CRVO Stock Holding History

Frontier Wealth Management’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-333	Closed	-$7K	–	402
2022 Q1	$7K	Hold	333	–	–	﹤0.01%	403
2021 Q4	$8K	Hold	333	–	–	﹤0.01%	425
2021 Q3	$13K	Hold	333	–	–	﹤0.01%	420
2021 Q2	$18K	Hold	333	–	–	﹤0.01%	423
2021 Q1	$23K	Hold	333	–	–	﹤0.01%	378
2020 Q4	$20K	Hold	333	–	–	﹤0.01%	373
2020 Q3	$21K	Buy	+333	New	+$25.3K	﹤0.01%	358

Other funds holding CRVO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Frontier Wealth Management's CRVO Position: Q2 2022 in Review

Frontier Wealth Management sold out of CervoMed (CRVO) in Q2 2022, closing a stake of 333 shares — an estimated $7K sold.

Frontier Wealth Management first reported a position in CRVO in Q3 2020 and held it in 7 quarters. The position peaked at $23K in Q1 2021. 15 funds tracked by Wall St. Rank hold CRVO as of Q2 2022.

Frontier Wealth Management reported no remaining CervoMed position as of Q2 2022 after selling out during the quarter.
Frontier Wealth Management sold 333 CervoMed shares in Q2 2022, an estimated $7K.
Frontier Wealth Management first reported a position in CervoMed in Q3 2020 and held it in 7 quarters.
Frontier Wealth Management's CervoMed position peaked at $23K in Q1 2021.
15 funds tracked by Wall St. Rank held CervoMed as of Q2 2022.

Based on Frontier Wealth Management's 13F filing for Q2 2022, filed 12 Aug 2022.